Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | X449Y | — |
a three-year-old patient after administrating Boostrix instead as a fourth dose; Boostrix administration out of the recommended age; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 3-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number X449Y, expiry date 20-OCT-2026) for prophylaxis. Co-suspect products included DTPa (Infanrix) for prophylaxis. On 25-JAN-2025, the patient received Boostrix. On an unknown date, the patient received Infanrix. On 25-JAN-2025, an unknown time after receiving Boostrix and not applicable after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: a three-year-old patient after administrating Boostrix instead as a fourth dose) and inappropriate age at vaccine administration (Verbatim: Boostrix administration out of the recommended age). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date : 31-MAR-2025 A Medical Assistant asked if they need to give an extra dose of Infanrix to a three-year-old patient after administrating Boostrix instead as a fourth dose in the administration schedule. The patient received Boostrix instead of Infanrix, which led to wrong vaccine administered and inappropriate age at vaccine administration.